Hap Trading, LLC Iovance Biotherapeutics, Inc. Put Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$6.38 - $18.33 $64,438 - $185,132	-10,100 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$12.38 - $19.1 $194,366 - $299,870	-15,700 Reduced 60.85%	10,100 $36,000
Q2 2021 Aug 11, 2021	BUY	$16.33 - $33.07 $258,013 - $522,506	15,800 Added 158.0%	25,800 $83,000
Q1 2021 May 14, 2021	BUY	$28.67 - $52.59 $286,700 - $525,900	10,000 New	10,000 $54,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.44B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.